S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin.

Švec X, Štorkánová H, Trinh-Minh T, Tran MC, Štorkánová L, Hulejová H, Oreská S, Heřmánková B, Bečvář R, Pavelka K, Vencovský J, Klingelhöfer J, Hussain RI, Hallén J, Šenolt L, Distler JHW, Tomčík M

Open source

DOI: 10.1093/rheumatology/kead295
Published: 2024 Mar 1
Container: Rheumatology (Oxford, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/kead295,
  title = {S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin.},
  author = {Švec X and Štorkánová H and Trinh-Minh T and Tran MC and Štorkánová L and Hulejová H and Oreská S and Heřmánková B and Bečvář R and Pavelka K and Vencovský J and Klingelhöfer J and Hussain RI and Hallén J and Šenolt L and Distler JHW and Tomčík M},
  year = {2024},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/kead295},
  url = {https://doi.org/10.1093/rheumatology/kead295}
}

RIS

TY  - JOUR
TI  - S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin.
AU  - Švec X
AU  - Štorkánová H
AU  - Trinh-Minh T
AU  - Tran MC
AU  - Štorkánová L
AU  - Hulejová H
AU  - Oreská S
AU  - Heřmánková B
AU  - Bečvář R
AU  - Pavelka K
AU  - Vencovský J
AU  - Klingelhöfer J
AU  - Hussain RI
AU  - Hallén J
AU  - Šenolt L
AU  - Distler JHW
AU  - Tomčík M
PY  - 2024
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/kead295
UR  - https://doi.org/10.1093/rheumatology/kead295
ER  -

APA

X, Š., H, Š., T, T., MC, T., L, Š., H, H., S, O., B, H., R, B., K, P., J, V., J, K., RI, H., J, H., L, Š., JHW, D., & M, T. (2024). S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/kead295

Source records

pubmed · retrieved 2026-09-27T13:41:28.594Z
europe-pmc · retrieved 2026-09-27T13:41:28.616Z